Researchers discovered how rabies virus exerts massive control over host cells with very few genes. A key viral protein ...

Sarepta Therapeutics, Inc. faces revenue decline, trial setbacks, and FDA decisions. Click for SRPT risks, outlook, and if ...

It’s a little after 6:30 on a brisk July morning in a stone hut high in the Italian Alps. A gently hissing wood fire is ...

The webcast and conference call may be accessed by visiting “Investor Events” on the investors section of the Wave Life Sciences website: Analysts planning to participate during the Q&A portion of ...

The most dangerous animal in the world just got easier to study-and perhaps defeat one day.

Within each cell, there is a constant struggle between life-sustaining molecules and molecules that could hasten its demise. For the first time, scientists have created a molecule that can identify ...

In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...

"We do really have to give President Trump credit for introducing the mRNA platform to the world through his leadership in ...

The most dangerous animal in the world just got easier to study—and perhaps defeat one day. Researchers from Rockefeller ...

This press release corrects and replaces the company’s press release issued today, 10/29, at 4:15 p.m. ET in order to correct a typographical ...

Dose-dependent mean reductions of Activin E of up to 85% one month post single dose of WVE-007 in INLIGHT clinical trial, exceeding levels that led to weight loss in preclinical models; WVE-007 is ...

Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing ...